Cheers TheDerivative for comments. CVA - cerebrovascular accident (stroke) at times has raised intracerebral pressures and raised sugar levels (ie. lends itself to Exanatide treatment). ADR is adverse drug reaction. CSF - cerebrospinal fluid. Don't think i can confirm the $1.6B market cap. This is the orphan indication. The real value here is the other markets it lends itself to. ie. get it to market with IIH orphan indication - which would be the shortest path - but I see value in multiple other medical indications (mentioned above) which it would be an adjuvant therapy. Its market potential is a lot bigger then IIH. I'm struggling to see where this falls over. not sure on Corporate structure though I've done some due diligence on the heads - all of which are incentivised with holdings.
IXC Price at posting:
96.0¢ Sentiment: Buy Disclosure: Held
